BullBD Old Apps Site
Home
Favorites
Recently viewed Details Chart Today news Share news Top gainer Top Looser Upcoming events
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0 1 2 3 4 5 6 7 8 9 All
Bank Cement Ceramics Sector Corporate Bond Engineering Financial Institutions Food & Allied Fuel & Power IT Sector Insurance Jute Life Insurance Miscellaneous Mutual Funds Paper & Printing Pharmaceuticals & Chemicals Services & Real Estate Tannery Industries Telecommunication Textile Travel & Leisure All
  • Details
  • Chart
  • News

ACMELAB

All Eps Dividend Board Agm Q1 Q2 Q3

ACMELAB 07-Nov-2019

As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on November 13, 2019 at 3.30 PM to consider, among others, un-audited financial statements of the Company for the First Quarter (Q1) period ended on September 30, 2019.

ACMELAB 31-Oct-2019

Trading of the Shares of the Company will resume on 03.11.2019 after record date.

ACMELAB 30-Oct-2019

Trading of the shares of the Company will remain suspended on record date i.e., 31.10.2019.

ACMELAB 28-Oct-2019

Trading of the shares of the Company will be allowed only in the Spot Market and Block transactions will also be settled as per Spot settlement cycle with cum benefit from 29.10.2019 to 30.10.2019. Trading of the shares of the Company will remain suspended on record date i.e., 31.10.2019.

ACMELAB 10-Oct-2019

There will be no price limit on the trading of the shares of the Company today (10.10.2019) following its corporate declaration.

ACMELAB 10-Oct-2019

The Board of Directors has recommended 35% cash dividend for the year ended on June 30, 2019. Date of AGM: 12.12.2019, Time: 10:30 AM, Venue: PSC Convention Hall, Mirpur-14, Dhaka-1206. Record Date: 31.10.2019. The Company has also reported EPS of Tk. 6.81, NAV per share of Tk. 86.69 and NOCFPS of Tk. 7.81 for the year ended on June 30, 2019 as against Tk. 6.74, Tk. 83.38 and Tk. 7.46 respectively for the same period of the previous year.

ACMELAB 02-Oct-2019

As per Regulation 19(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on October 09, 2019 at 3:30 PM to consider, among others, audited financial statements of the Company for the year ended on June 30, 2019.

ACMELAB 02-Jul-2019

The Company has informed that the Board of Directors has declared the commencement of Commercial Production of its state of the art Steroid and Hormone facility at Dulivita, Dhamrai, Dhaka after successful completion of trial production. The Company noted that the aforesaid Steroid and Hormone facility is second of the three projects against which fund was raised through Initial Public Offering (IPO).

ACMELAB 13-Jun-2019

The Company has informed that the Board of Directors has declared the commencement of Commercial Production of its state of the art Penicillin facility at Dulivita, Dhamrai, Dhaka after successful completion of trial production. The Company noted that the aforesaid Penicillin facility is one of the three projects against which fund was raised through Initial Public Offering (IPO).

ACMELAB 29-Apr-2019

(Q3 Un-audited): EPS was Tk. 1.74 for January-March 2019 as against Tk. 1.85 for January-March 2018; EPS was Tk. 5.43 for July 2018-March 2019 as against Tk. 5.66 for July 2017-March 2018. NOCFPS was Tk. 5.15 for July 2018-March 2019 as against Tk. 6.80 for July 2017-March 2018. NAV per share was Tk. 85.32 as on March 31, 2019 and Tk. 83.39 as on June 30, 2018.

Previous Next page